Protein MGC27345: A Potential Drug Target and Biomarker (G157247)

Target Name: Uncharacterized protein MGC27345

NCBI ID: G157247

Uncharacterized protein MGC27345

Other Name(s): MGC27345

Protein MGC27345: A Potential Drug Target and Biomarker

Protein MGC27345 (MGC27345) is a unique and uncharacterized protein that has been identified as a potential drug target and biomarker. MGC27345 is a 21-kDa protein that is expressed in various cell types, including human placenta, brain, and heart. It is characterized by a unique N-terminus, a characteristic that is rare in proteins. The protein is also known for its potential role in cell signaling, as well as its involvement in various cellular processes.

MGC27345: A Potential Drug Target

The identification of protein MGC27345 as a potential drug target is based on its unique structure and various biochemical, cellular, and functional characteristics. MGC27345 is a member of the gene family known as the heat shock protein (HSP) family. This family of proteins is known for their ability to withstand and recover from various forms of stress, such as increased temperatures, reactive oxygen species, and heavy metals.

One of the unique features of MGC27345 is its N-terminus, which is rich in conserved regions that are involved in protein-protein interactions and other cellular processes. This N-terminus region is known as the N-terminal hypervariable region (HVR) and has been implicated in various cellular processes, including cell signaling, DNA replication, and stress response.

In addition to its unique N-terminus, MGC27345 is also characterized by its ability to interact with various proteins and other molecules. For example, MGC27345 has been shown to interact with the protein heat shock protein (HSP70), which is known for its role in stress response and DNA replication. MGC27345 has also been shown to interact with the transcription factor p53, which is involved in various cellular processes, including DNA replication, apoptosis, and stress response.

MGC27345's potential as a drug target is based on its involvement in various cellular processes that are associated with various diseases, including cancer, neurodegenerative diseases, and autoimmune diseases. For example, MGC27345 has been shown to be involved in the regulation of cell cycle progression, which is a critical process for the development and progression of cancer. It has also been shown to be involved in the regulation of DNA replication, which is critical for the development and progression of neurodegenerative diseases.

MGC27345 as a Biomarker

MGC27345 has also been identified as a potential biomarker for various diseases. For example, MGC27345 has been shown to be involved in the regulation of cell cycle progression, which is a critical process for the development and progression of cancer. This is associated with the high incidence of cancer, which is a major public health problem.

MGC27345 has also been shown to be involved in the regulation of DNA replication, which is critical for the development and progression of neurodegenerative diseases. This is associated with the high incidence of neurodegenerative diseases, which are also a major public health problem.

Conclusion

In conclusion, protein MGC27345 is a unique and uncharacterized protein that has been identified as a potential drug target and biomarker. Its unique N-terminus and various biochemical, cellular, and functional characteristics make it an attractive candidate for further investigation. The potential drug target and biomarker properties of MGC27345 make it a promising target for the development of new therapies for various diseases.

Keywords: Uncharacterized protein, MGC27345, drug target, biomarker, heat shock protein, N-terminus, cell signaling, DNA replication, neurodegenerative diseases, cancer.

Protein Name: Uncharacterized Protein MGC27345

The "Uncharacterized protein MGC27345 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about Uncharacterized protein MGC27345 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets